Biohaven (NYSE:BHVN) Price Target Cut to $68.00 by Analysts at JPMorgan Chase & Co.
Biohaven (NYSE:BHVN – Free Report) had its price target reduced by JPMorgan Chase & Co. from $72.00 to $68.00 in a research report sent to investors on Wednesday,Benzinga reports. They currently have an overweight rating on the stock. A number of other equities research analysts also recently commented on BHVN. Deutsche Bank Aktiengesellschaft started coverage […]
